Assessing 24-hour blood glucose patterns in diabetic paitents treated by
peritoneal dialysis.
Authors Schwing WD, Erhard P, Newman LN, Nodge MM, Czechanski BJ, Orlin SM, Walden SM,
Behm K, Cacho CP, Negrea LA, Siu DS, Kern EO, Weiss MF
Submitted By Submitted Externally on 10/1/2015
Status Published
Journal Advances in peritoneal dialysis. Conference on Peritoneal Dialysis
Year 2004
Date Published
Volume : Pages 20 : 213 - 6
PubMed Reference 15384829
Abstract The minute-to-minute effect on blood glucose levels of high-dextrose peritoneal
dialysate is not known. We arranged for 7 patients with diabetes, treated by
peritoneal dialysis (PD), to wear a continuous glucose monitoring system (CGMS:
Medtronic MiniMed, Northridge, CA, U.S.A.). A sensor was inserted subcutaneously
into the skin of the patient's abdomen or back to measure glucose in the
interstitial fluid. Readings were recorded every 5 minutes for up to 72 hours.
The portion of the day during which the patient's blood glucose levels were
greater than 180 mg/dL (calculated as a percentage of time) was recorded. Most
of the patients participating in the study had elevated levels of
glycohemoglobin and hemoglobin A1c, and, for a large percentage of the day,
showed blood glucose tracings well above the recommended standards of control.
Representative CGMS tracings from patients with type 1 and type 2 diabetes are
shown.

Complications